Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use

EG Giannini, G Sammito, F Farinati, F Ciccarese… - Cancer, 2014 - Wiley Online Library
BACKGROUND α‐Fetoprotein (AFP) is a biomarker commonly used in the management of
patients with hepatocellular carcinoma (HCC), although the possible determinants of its …

[引用][C] Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.

E Giannini, G Sammito, F Farinati, F Ciccarese… - CANCER, 2014 - iris.unina.it
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications
for its clinical use. IRIS IRIS Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT …

Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use

EG Giannini, G Sammito, F Farinati, F Ciccarese… - Cancer, 2014 - pubmed.ncbi.nlm.nih.gov
Background α-Fetoprotein (AFP) is a biomarker commonly used in the management of
patients with hepatocellular carcinoma (HCC), although the possible determinants of its …

[PDF][PDF] Determinants of Alpha-Fetoprotein Levels in Patients With Hepatocellular Carcinoma

MD Giuseppe Cabibbo, MD Antonio Gasbarrini… - Cancer, 2014 - academia.edu
Determinants of Alpha-Fetoprotein Levels in Patients With Hepatocellular Carcinoma Page 1
Determinants of Alpha-Fetoprotein Levels in Patients With Hepatocellular Carcinoma …

[引用][C] Determinants of Alpha-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: Implications for its Clinical Use

EG GIANNINI, G SAMMITO, G CABIBBO, M FELDER… - Cancer, 2014 - pascal-francis.inist.fr
Determinants of Alpha-Fetoprotein Levels in Patients With Hepatocellular Carcinoma:
Implications for its Clinical Use CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use

EG Giannini, G Sammito, F Farinati, F Ciccarese… - CANCER, 2014 - iris.univpm.it
α-Fetoprotein (AFP) is a biomarker commonly used in the management of patients with
hepatocellular carcinoma (HCC), although the possible determinants of its serum levels in …

Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use

EG Giannini, G Sammito, F Farinati, F Ciccarese… - CANCER, 2014 - air.unipr.it
BACKGROUND: alpha-Fetoprotein (AFP) is a biomarker commonly used in the
management of patients with hepatocellular carcinoma (HCC), although the possible …

[引用][C] Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use

EG Giannini, G Sammito, F Farinati, F Ciccarese… - Cancer, 2014 - cir.nii.ac.jp
Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma:
Implications for its clinical use | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Determinants of alpha‐fetoprotein levels in patients with hepatocellular carcinoma: Implications for its clinical use

EG Giannini, G Sammito, F Farinati, F Ciccarese… - Cancer, 2014 - infona.pl
BACKGROUND α‐Fetoprotein (AFP) is a biomarker commonly used in the management of
patients with hepatocellular carcinoma (HCC), although the possible determinants of its …

Determinants of alpha-fetoprotein levels in patients with hepatocellular carcinoma: implications for its clinical use.

EG Giannini, G Sammito, F Farinati, F Ciccarese… - Cancer, 2014 - europepmc.org
Background α-Fetoprotein (AFP) is a biomarker commonly used in the management of
patients with hepatocellular carcinoma (HCC), although the possible determinants of its …